Do These 3 Checks Before Buying Shanghai Rongtai Health Technology Corporation Limited (SHSE:603579) For Its Upcoming Dividend
Do These 3 Checks Before Buying Shanghai Rongtai Health Technology Corporation Limited (SHSE:603579) For Its Upcoming Dividend
Shanghai Rongtai Health Technology Corporation Limited (SHSE:603579) stock is about to trade ex-dividend in four days. The ex-dividend date occurs one day before the record date which is the day on which shareholders need to be on the company's books in order to receive a dividend. The ex-dividend date is of consequence because whenever a stock is bought or sold, the trade takes at least two business day to settle. In other words, investors can purchase Shanghai Rongtai Health Technology's shares before the 5th of June in order to be eligible for the dividend, which will be paid on the 5th of June.
榮泰健康(SHSE:603579)股票將於四天後交易的股息分派。 股息分派日期是股東需要在公司的股東名冊上註冊的日子的前一天,以便獲得股息。 股息分派日期是重要的,因爲每當買入或賣出股票,交易需要至少兩個營業日才能結算。 換言之,投資者可以在6月5日之前購買榮泰健康的股票,以符合有權獲得於6月5日派發的股息的資格。
The company's next dividend payment will be CN¥1.00 per share, on the back of last year when the company paid a total of CN¥1.00 to shareholders. Last year's total dividend payments show that Shanghai Rongtai Health Technology has a trailing yield of 4.1% on the current share price of CN¥24.10. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid. So we need to check whether the dividend payments are covered, and if earnings are growing.
該公司的下一個股息派付金額爲每股人民幣1.00元,上一年公司向股東支付了總額爲1.00元的股息。 去年的總股息支付顯示,榮泰健康的股息收益率爲4.1%,基於當前的股價室人民幣24.10元。 長揸者的投資回報中,股息是一個主要貢獻者,但只要股息繼續支付。 所以我們需要檢查分紅是否被覆蓋,以及利潤是否增長。
Dividends are usually paid out of company profits, so if a company pays out more than it earned then its dividend is usually at greater risk of being cut. Shanghai Rongtai Health Technology is paying out an acceptable 59% of its profit, a common payout level among most companies. Yet cash flows are even more important than profits for assessing a dividend, so we need to see if the company generated enough cash to pay its distribution. The company paid out 94% of its free cash flow over the last year, which we think is outside the ideal range for most businesses. Cash flows are usually much more volatile than earnings, so this could be a temporary effect - but we'd generally want to look more closely here.
股息通常是從公司利潤中支付的,因此,如果一家公司支付的股息超過其所賺的利潤,則其股息通常面臨更大的風險被削減。 榮泰健康支付了可接受的59%的利潤,這是大多數公司的常見支付水平。 但是,現金流對於評估股息的重要性甚至比利潤更重要,因此,我們需要看到公司是否有足夠的現金來支付其分配。 該公司在過去一年中支付了其自由現金流的94%,我們認爲這超出了大多數業務的理想範圍。 現金流通常比收益波動得多,因此這可能是一種暫時的效應 - 但我們通常希望在這裏更仔細地觀察。
While Shanghai Rongtai Health Technology's dividends were covered by the company's reported profits, cash is somewhat more important, so it's not great to see that the company didn't generate enough cash to pay its dividend. Cash is king, as they say, and were Shanghai Rongtai Health Technology to repeatedly pay dividends that aren't well covered by cashflow, we would consider this a warning sign.
儘管榮泰健康的股息由公司報告的利潤所覆蓋,但現金更爲重要,因此看到該公司未能產生足夠的現金支付其股息並不好。 正如他們所說,現金是王者,如果榮泰健康反覆支付未經現金流覆蓋的股息,我們將視爲一個預警信號。
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
點擊此處查看公司的支付比率以及未來分紅的分析師預期。
![historic-dividend](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240601/0-faaefb0c3658ffc660184d1da3bb9347-0-86402a5b4d5672c752d938f56a6feccb.png/big)
Have Earnings And Dividends Been Growing?
收益和股息一直在增長嗎?
Companies that aren't growing their earnings can still be valuable, but it is even more important to assess the sustainability of the dividend if it looks like the company will struggle to grow. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. It's not encouraging to see that Shanghai Rongtai Health Technology's earnings are effectively flat over the past five years. We'd take that over an earnings decline any day, but in the long run, the best dividend stocks all grow their earnings per share.
即使企業沒有增長其收益,它們仍然有價值,但如果看起來該企業將難以增長,則評估股息的可持續性就更加重要。 如果企業陷入困境並削減了股息,則該公司的價值可能會急劇下降。 看到榮泰健康的收益在過去五年中基本上保持不變並不令人鼓舞。 在任何一天,我們都會採取這種方式,但從長遠來看,最好的股息股票都會增加每股收益。
Another key way to measure a company's dividend prospects is by measuring its historical rate of dividend growth. In the last seven years, Shanghai Rongtai Health Technology has lifted its dividend by approximately 19% a year on average.
衡量公司股息前景的另一個關鍵方式是測量其歷史股息增長率。 在過去七年中,榮泰健康的股息平均每年增長約19%。
The Bottom Line
還有一件事需要注意的是,我們已經確定了上海醫藥的2個警告信號,了解這些信號應該成爲你的投資過程的一部分。
From a dividend perspective, should investors buy or avoid Shanghai Rongtai Health Technology? It's not great to see earnings per share have been flat and that the company paid out an uncomfortably high percentage of its cash flow over the past year. Cash flows are typically more volatile than earnings, but this is still not what we like to see. It's not an attractive combination from a dividend perspective, and we're inclined to pass on this one for the time being.
從股息的角度來看,投資者應該買入榮泰健康還是避免榮泰健康? 着眼於每股收益持平以及公司在過去一年中支付了不舒適的高比例現金流的情況並不好。 現金流通常比收益更具波動性,但這仍然不是我們想看到的。 從股息的角度來看,這不是一個優秀的組合,因此我們傾向於目前不進行投資。
With that in mind though, if the poor dividend characteristics of Shanghai Rongtai Health Technology don't faze you, it's worth being mindful of the risks involved with this business. Every company has risks, and we've spotted 1 warning sign for Shanghai Rongtai Health Technology you should know about.
考慮到這一點,如果榮泰健康的股息特徵並不讓你感到沮喪,那麼值得注意該業務所涉及的風險。 每家公司都有風險,我們已經發現了1個關於榮泰健康的警告信號。
If you're in the market for strong dividend payers, we recommend checking our selection of top dividend stocks.
如果你在尋找強勁的股息支付者,我們建議查看我們的頂級股息股票選擇。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?關於內容有所顧慮?直接和我們聯繫。或電郵 editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。